CLINICAL VALUE OF FLUOROQUINOLONE IN THE TREATMENT OF TB AND MDR-TB

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SAYADI MAHDIYE; SAYADI MAHSA; GHAZVINI KIARASH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES Year:2018 | Volume:60 | Issue:5 Page(s): 714-726

Download Full-Text

Persian Verion

View:

1,175

Download:

Cites:

Information Journal Paper

Title

CLINICAL VALUE OF FLUOROQUINOLONE IN THE TREATMENT OF TB AND MDR-TB

Author(s)

SAYADI MAHDIYE | SAYADI MAHSA | GHAZVINI KIARASH | Issue Writer Certificate

Keywords

FLUOROQUINOLONEQ1

ANTIBIOTIC RESISTANCEQ2

MDR-TBQ1

THE SECOND PHASE OF TB TREATMENTQ1

Abstract

Background: Tuberculosis is a major health problem in many developing countries. The disease is caused by Mycobacterium tuberculosis bacilli, for the treatment antibiotics such as isoniazid, rifampin, pyrazinamide and ethambutol are used, Due to the reduced activity of these antibiotics and increase the resistance and MDR strains around the world, need to consider antibiotics second phase of TB treatment and alternative therapies felt. Among the second phase of treatment drugs, FLUOROQUINOLONE are the most important drugs as THE SECOND PHASE OF TB TREATMENT because of high pharmoacokenetics and pharmaco dynamic properties, Broad activity against Mycobacterium tuberculosis and less side effects and toxicity. As currently only FLUOROQUINOLONE is approved by the World Health Organization to be used in the treatment of sensitive TB and proved that their use shortens the duration of treatment and improve results. Materials&Methods: In the present study, 170 Article about FLUOROQUINOLONE in the treatment of pulmonary tuberculosis and MDR-TB have been reviewed. Results: According to the articles, FLUOROQUINOLONE are the latest and most powerful drug classes used in THE SECOND PHASE OF TB TREATMENT and In addition to being effective in the treatment of MDR-TB, affordable alternative to antibiotics in the first phase standard diet. Among the members of this groupof antibiotics, Moxifloxacin and levofloxacin of which have the greatest activity and Have higher activity than ofloxacinBut there ofloxacin higher safetyConclusion: FLUOROQUINOLONE, as appropriate antibiotic for the treatment of MDR-TB as well as a better alternative to antibiotics in the first line.

Cites

No record.

References

No record.

Cite

APA: Copy

SAYADI, MAHDIYE, SAYADI, MAHSA, & GHAZVINI, KIARASH. (2018). CLINICAL VALUE OF FLUOROQUINOLONE IN THE TREATMENT OF TB AND MDR-TB. MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES, 60(5 ), 714-726. SID. https://sid.ir/paper/52349/en

Vancouver: Copy

SAYADI MAHDIYE, SAYADI MAHSA, GHAZVINI KIARASH. CLINICAL VALUE OF FLUOROQUINOLONE IN THE TREATMENT OF TB AND MDR-TB. MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2018;60(5 ):714-726. Available from: https://sid.ir/paper/52349/en

IEEE: Copy

MAHDIYE SAYADI, MAHSA SAYADI, and KIARASH GHAZVINI, “CLINICAL VALUE OF FLUOROQUINOLONE IN THE TREATMENT OF TB AND MDR-TB,” MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES, vol. 60, no. 5 , pp. 714–726, 2018, [Online]. Available: https://sid.ir/paper/52349/en

Related Journal Papers